Insider Transactions in Q4 2018 at Amgen Inc (AMGN)
Insider Transaction List (Q4 2018)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 06
2018
|
Tyler Jacks Director |
SELL
Open market or private sale
|
Direct |
20,000
-69.02%
|
$3,900,000
$195.41 P/Share
|
|
Dec 06
2018
|
Tyler Jacks Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+40.83%
|
$1,640,000
$82.6 P/Share
|
|
Nov 30
2018
|
David Piacquad SVP, Business Development |
SELL
Payment of exercise price or tax liability
|
Direct |
4,109
-9.11%
|
$830,018
$202.37 P/Share
|
|
Nov 30
2018
|
David Piacquad SVP, Business Development |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+12.59%
|
$351,000
$54.69 P/Share
|
|
Nov 29
2018
|
Cynthia M Patton SVP & CCO |
SELL
Open market or private sale
|
Direct |
1,777
-7.7%
|
$358,954
$202.88 P/Share
|
|
Nov 29
2018
|
Cynthia M Patton SVP & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,777
+7.15%
|
$95,958
$54.69 P/Share
|
|
Nov 05
2018
|
Charles M Holley Director |
BUY
Grant, award, or other acquisition
|
Direct |
93
+6.12%
|
-
|
|
Nov 02
2018
|
Murdo Gordon EVP, Global Commercial Ops |
BUY
Grant, award, or other acquisition
|
Direct |
34,213
+50.0%
|
-
|
|
Nov 02
2018
|
Ellen Jamison Kullman Director |
BUY
Grant, award, or other acquisition
|
Direct |
149
+4.31%
|
-
|
|
Nov 02
2018
|
David M Reese EVP & Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,830
+29.53%
|
-
|